| Literature DB >> 31774591 |
Hadi Dolati1, Lisa C Haufe1, Lars Denker1, Andreas Lorbach2, Robin Grotjahn3, Gerald Hörner3,4, René Frank1.
Abstract
(aza-)BODIPY dyEntities:
Keywords: BODIIM; BODIPY; bisimidazoles; fluorescent dyes; switchable fluorescence
Year: 2020 PMID: 31774591 PMCID: PMC7027818 DOI: 10.1002/chem.201905344
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236
Scheme 1Structures of compounds 1–6.
Scheme 2Key conditions and reagents. i) 1 equiv. nBuLi, THF, −30 °C, 30 min, then 0.45 equiv. benzoyl chloride, 0 °C to rt, 1 h, 65 %. ii) 0.5 equiv. BH2Cl⋅SMe2, DCM, 0 °C to rt, 15 min, then THF, 15 min, then hexanes, 95 %. iii) 2.05 equiv. nBuLi, THF, −78 °C to rt, overnight, then 1.05 equiv. methyl benzoate, rt, 1 h, aqueous work‐up with brine, 95 %. iv) 1.05 equiv. Na[N(SiMe3)2], THF, −78 °C to rt, 3 h, then 3 equiv. MeI, rt, 12 h, aqueous workup with brine, 96 %. v) 4 equiv. KC8, THF, 0 °C, 15 min, 95 %.
Figure 1Molecular structures of compounds 6 (left) and 10 (right). The phenyl entity is represented in the wireframe model. Thermal ellipsoids are drawn at the 50 % probability level. Solvent molecules (chloroform) in the structure of 10 are omitted. Selected bond lengths (Å) and bond angles (°) for 6: B1−N1 1.546(1), B1−N3 1.550(1), C8−N3 1.356(1), C1−C8 1.413(1), C1−C2 1.417(1), C1−C14 1.490(1), C2−N1 1.357(1), C8‐C1‐C14 121.95(9), C2‐C1‐C14 122.73(9), C2‐C1‐C8 115.17(9); for 10: B1−N1 1.553(3), B1−N3 1.553(3), C8−N3 1.326(3), C1−C8 1.512(3), C1−C2 1.513(3), C1−C14 1.534(3), O1−C1 1.412(3), C2−N1 1.323(3), C8‐C1‐C14 107.90(18), C2‐C1‐C14 109.06(18), C2‐C1‐C8 108.56(18).
Figure 2Selected molecular orbitals for BODIPY (A, B) and BODIIM (C, D) systems as obtained by DFT calculations (B3LYP‐D3/TZVP/COSMO(THF)). The addition of 2 π‐electrons to the LUMO in BODIPY systems retains the HOMO in the novel BODIIM system with preservation of the characteristic atomic orbital contributions.
Figure 3Comparison of the optical properties of BODIPY reference compound B (data reported in Ref. 17, recorded in toluene) and BODIIM 6 (recorded in toluene). i) Solution of compound 6 in toluene at ambient light. ii) Solution of compound 6 in toluene with UV‐lamp excitation (λ≈366 nm). λ abs,max: wavelength at the maximum of absorbance, λ em,max: wavelength at the maximum emission intensity, ΦF: fluorescence quantum yield.
Figure 4Experimental absorption spectra of 6. Insert: Calculated absorption spectra of 6 using empirically corrected CAM‐B3LYP/cc‐pVDZ TD‐DFT excitation energies at PBE0/def2‐TZVP structures and a Gaussian broadening of FWHM=0.25 eV.
Figure 5Experimental fluorescence spectra of compound 6. Insert: Calculated emission spectra of 6 at wB97XD/def2‐TZVP TD‐DFT level of theory. Oscillatory strengths were normalized to 1.0 at λ max in THF.
Scheme 3Key conditions and reagents. i) 1.3 equiv. BH3⋅SMe2 or MesBH2, toluene, rt, 30 min, 75 % (12) or 70 % (14). ii) 1 equiv. NHC, C6D6, rt, 5 % (12) or quantitative (14). Mes=2,4,6‐Me3C6H2.
Figure 6Molecular structure of compounds 12 (left) and 14 (right). The phenyl and mesityl entity are represented in the wireframe model. Thermal ellipsoids are drawn at the 50 % probability level. Carbon bound hydrogen atoms are omitted. The illustrated molecule for 12 is located on a crystallographic mirror plane containing B1, C1, B2 and the phenyl entity. Selected bond lengths [Å] and bond angles [°] for 12: B1−N2 1.5443(16), C1−C2 1.4975(14), C2−N2 1.3330(15), C1−B2 1.679(2), C2‐C1‐C2' 108.16(13), C2‐C1‐B2 106.34(9), N2‐B1‐N2' 105.03(14); for 14: B1−N2 1.5519(17), B1−N4 1.5543(18), C1−B2 1.734(2), C2−N2 1.3368(16), C8−N4 1.3340(16), C1−C2 1.5033(18), C1−C8 1.4989(17), N2‐B1‐N4 104.24(10), C8‐C1‐C2 107.40(10).
Figure 7Upon irradiation (UV‐lamp, λ≈366 nm) NMR‐solutions of compound 6 and 14 (0.1 m in C6D6) show intense green fluorescence (6) and weak blue fluorescence (14).